Advantest (ATEYY)
(Delayed Data from OTC)
$46.30 USD
+0.44 (0.96%)
Updated Sep 25, 2024 03:50 PM ET
2-Buy of 5 2
F Value B Growth C Momentum D VGM
Income Statements
Fiscal Year end for Advantest Corp falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | 3,357 | 4,145 | 3,710 | 2,940 | 2,538 |
Cost Of Goods | 1,659 | 1,784 | 1,611 | 1,358 | 1,098 |
Gross Profit | 1,698 | 2,361 | 2,100 | 1,582 | 1,440 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,134 | 1,120 | 1,078 | 917 | 900 |
Income After Depreciation & Amortization | 563 | 1,241 | 1,021 | 665 | 540 |
Non-Operating Income | 9 | 33 | 17 | 7 | 10 |
Interest Expense | 32 | 6 | 3 | 18 | 11 |
Pretax Income | 539 | 1,267 | 1,035 | 654 | 539 |
Income Taxes | 110 | 302 | 258 | -2 | 46 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 430 | 965 | 777 | 656 | 492 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 430 | 965 | 777 | 656 | 492 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 743 | 1,399 | 1,154 | 775 | 640 |
Depreciation & Amortization (Cash Flow) | 180 | 158 | 133 | 111 | 100 |
Income After Depreciation & Amortization | 563 | 1,241 | 1,021 | 665 | 540 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | 740.14 | 750.83 | 780.76 | 793.44 | 796.13 |
Diluted EPS Before Non-Recurring Items | 0.58 | 1.29 | 1.00 | 0.83 | 0.62 |
Diluted Net EPS (GAAP) | 0.58 | 1.29 | 1.00 | 0.83 | 0.62 |
Fiscal Year end for Advantest Corp falls in the month of March .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 889.88 | 909.59 | 905.98 | 802.19 | 739.13 |
Cost Of Goods | NA | 442.75 | 447.75 | 401.59 | 367.19 |
Gross Profit | NA | 466.83 | 458.23 | 400.60 | 371.94 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 335.11 | 275.79 | 255.70 | 267.78 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 131.72 | 182.44 | 144.90 | 104.16 |
Non-Operating Income | NA | 2.51 | 2.19 | 1.74 | 2.15 |
Interest Expense | NA | 8.43 | 6.13 | 6.18 | 11.69 |
Pretax Income | NA | 125.80 | 178.50 | 140.46 | 94.62 |
Income Taxes | NA | 22.85 | 34.31 | 24.98 | 27.44 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 153.14 | 102.95 | 144.19 | 115.48 | 67.17 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 153.14 | 102.95 | 144.19 | 115.48 | 67.17 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 738.01 | 740.69 | 740.14 | 739.88 | 736.91 |
Diluted EPS Before Non-Recurring Items | 0.21 | 0.14 | 0.19 | 0.16 | 0.09 |
Diluted Net EPS (GAAP) | 0.21 | 0.14 | 0.19 | 0.16 | 0.09 |